secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pluri Inc. (PLUR)
CIK:        0001158780
Form:       8-K
Filed at:   2022-12-28T23:59:59+00:00
Accession:  0001213900-22-083223
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pluri announces cultivated meat JV with Tnuva reaches proof of concept; CEO takes salary cut for equity
--------------------------------------------------------------------------------

- Joint venture with Tnuva Group reached proof of concept in cultivated meat development using Pluri's 3D cell platform.
- New biologics partnership with European API manufacturer for liver and gastroenterological disease treatments.
- Company reduced cash burn by ~30% and secured $8.4M new investment via securities purchase agreements.
- CEO Yaky Yanay foregoes $375,000 cash salary over 12 months in exchange for equity grants.
- EU Horizon Europe awarded €7.5M non-dilutive grant for knee osteoarthritis study using PLX-PAD cells.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158780/000121390022083223/0001213900-22-083223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158780/000121390022083223/ea170946-8k_pluriinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-083223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer